Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Meperidine belongs to a class of drugs known as opioids, and is an analgesic similar to morphine. Meperidine was originally approved in 1942. Meperidine is available in different dosage forms such as tablets, syrup, oral solution, and injectable solutions. Meperidine is indicated for the management of severe pain which cannot be controlled by alternative treatments due to which opioid medication becomes necessary. Meperidine is legally available under the Controlled Substance Act (CSA) and under the drug class - schedule II drug in the U.S. The substances which have a high potential for abuse and which may lead to severe psychological or physical dependence come under schedule II drug class.

The global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020 and is expected to increase to US$ 2,784.3 Mn by 2027, witnessing a CAGR of 4.2% during the forecast period (2020-2027).

Figure 1. Global Meperidine (Demerol) Market Share (%), By Value, By Region (2019)

Meperidine (Demerol)  | Coherent Market Insights

The increasing number of surgical procedures are expected to drive the global meperidine (Demerol) market growth

Opioids such as meperidine are used as pre-anesthetic medication in the surgical procedure, and are also used as part of anesthesia to prevent pain after surgical procedure. Opioids are also used in surgical treatment related to cancer. They are also used in cardiovascular procedures to obtain the relief from post-surgical treatment pain. The increasing number of surgeries worldwide is expected to support growth of the market during the forecast period. For instance, according to Eurostat, 2019, there were at least 1.4 million caesarean sections performed in the EU in 2017. Moreover, pain management related to cancer disease, back pain, neuropathic pain, migraine, osteoarthritis, and pain which occurs after the surgical procedures also involves use of opioids such as meperidine. The rising prevalence of such diseases is expected to support global meperidine (Demerol) market growth during the forecast period.

The rising prevalence of conditions such as cancer and other pain related diseases is expected to support global meperidine (Demerol) market growth during the forecast period.

In many disease cases, there is no cure for chronic pain, therefore physicians prefer pharmacological methods to treat the pain and decrease the suffering. The patients suffering from intractable chronic pain, which cannot be managed with conventional treatment methods may require opioid drug therapy, especially for chronic diseases such as cancer. The pain does not stop after the treatment in cancer, and to get relief from this continuous and long lasting pain, patients prefer to use opioid drugs such as meperidine. Thus, the increasing prevalence of diseases such as cancer is expected to support the global meperidine (Demerol) market growth during the forecast period. According to the World Health Organization’s 2018 report, cancer was the second leading cause of morbidity and mortality worldwide and was responsible for an estimated 9.6 million deaths in 2018. According to the same source, globally, around 1 in 6 deaths occur due to cancer annually.

Global Meperidine (Demerol) Market - Regional Analysis

Regional segmentation of the global meperidine (Demerol) market includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to witness significant growth during the forecast period owing to the increasing prevalence of pain causing conditions such as osteoarthritis in the region. For instance, according to the Centers for Disease Control and Prevention’s (CDC) report, osteoarthritis affected more than 30 million U.S adults in 2018, and it has been estimated that 70 million people are likely to suffer from osteoarthritis by 2040.

Asia Pacific is also expected to witness growth in the global meperidine (Demerol) market owing to presence of a vast customer base, and a number of generic manufacturers in the region.

Figure 2:  Global Meperidine (Demerol) Market Value (US$ Mn) Analysis and Forecast & Y-o-Y Growth (%), (2019-2027)

Meperidine (Demerol)  | Coherent Market Insights

Restraints

Factors such as increasing drug/opioid addiction, presence of alternative opioid medications, and side effects such as accumulation of toxic metabolite normeperidine, and possible generalized seizures affecting both cerebral hemispheres and loss of consciousness may restrict the global meperidine (Demerol) market growth during the forecast period.

Key Players

Key players covered as a part of this market are Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc.

The meperidine is also known as pethidine. It is a synthetic opioid analgesic and used in pain management. It is also used to treat rigors and in post anesthesia-shivers. Several physicians prefer to prescribe meperidine for the treatment of acute and chronic severe pain as it has lesser risk of addiction and is safer than morphine. However, due to the short duration of action, low potency and toxicity of meperidine compared to other opioid analgesics, the preference for meperidine among physicians has reduced in the recent years.

Market Dynamics

The growing demand for meperidine is associated with its increasing use as an anesthetic in different surgical procedures. According to the World Health Organization (WHO), around 232 million surgeries were reported in 2013, suggesting that the increase in number of surgical procedures is expected to support the growth of meperidine segment in the near future. Moreover, as per the Centers for Disease Control and Prevention (CDC), in 2014, surgical procedures were the second largest contributors in opioid prescriptions and contributed around 37% in total opioid prescriptions in the U.S. These factors are expected to support the global meperidine (Demerol) market growth during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global meperidine (Demerol) market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period: 2020- 2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global meperidine (Demerol) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study are Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., Teva Pharmaceutical Industries Ltd., and Vintage Pharmaceuticals, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, end user upgrades, market expansion, and marketing tactics
  • The global meperidine (Demerol) market report caters to various stakeholders in this industry, including investors, device/system manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the meperidine (Demerol) market would provide stakeholders vital inputs to make strategic decisions

Detailed Segmentation

  • Global Meperidine (Demerol) Market, By Dosage Form:
    • Tablet
    • Injection
    • Syrup
  • Global Meperidine (Demerol) Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Meperidine (Demerol) Market, By Region:
    • North America
      • By Dosage Form:
        • Tablet
        • Injection
        • Syrup
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Dosage Form:
        • Tablet
        • Injection
        • Syrup
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Latin America
      • By Dosage Form:
        • Tablet
        • Injection
        • Syrup
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Asia Pacific
      • By Dosage Form:
        • Tablet
        • Injection
        • Syrup
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Dosage Form:
        • Tablet
        • Injection
        • Syrup
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Dosage Form:
        • Tablet
        • Injection
        • Syrup
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Strategies
    • Hikma Pharmaceuticals USA Inc.
    • Epic Pharma, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Vintage Pharmaceuticals, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Dosage Form
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Industry Trend
    • Mergers and Acquisitions
    • Product Profiles
    • Key Developments
  4. Global Meperidine (Demerol) Market, By Dosage Form, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 - 2027
      • Segment Trends
    • Tablet
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Syrup
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  5. Global Meperidine (Demerol) Market, By Distribution Channel, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 - 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  6. Global Meperidine (Demerol) Market, By Region, 2016 - 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017 - 2027
    • North America
      • Market Size and Forecast, By Dosage Form, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 20176– 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Dosage Form, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 20176– 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Dosage Form, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 20176– 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Dosage Form, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 20176– 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Dosage Form, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 20176– 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Dosage Form, 2016 – 2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 20176– 2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027 (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Hikma Pharmaceuticals USA Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Epic Pharma, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Vintage Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 26 figures on "Meperidine (Demerol) Market - Global forecast to 2027”.

Frequently Asked Questions

The global meperidine (Demerol) market is estimated to be valued at US$ 2,089.1 Mn in 2020 and is expected to increase to US$ 2,784.3 Mn by 2027, witnessing a CAGR of 4.2% during the forecast period (2020-2027).
The tablets segment held a major market share in 2019 owing to the increasing demand for oral meperidine tablets for pain management.
Major factors driving the growth of global meperidine (Demerol) market during the forecast period are the increasing prevalence of chronic diseases, and the rising number of surgical procedures.
Major factors hampering the growth of the meperidine (Demerol) market during the forecast period are the presence of alternative opioid medication and side effects of meperidine.
North America meperidine (Demerol) market is expected to hold the highest share during the forecast period.
Some of the key players operating in the market are Pfizer, Inc., Hikma Pharmaceuticals USA Inc., Epic Pharma, Inc., and Vintage Pharmaceuticals, Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner